• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAardvark Therapeutics
    Picture of Aardvark Therapeutics logo

    AARD — Aardvark Therapeutics News Story

    $3.860.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    • Market Cap
      $84.48m
    • Enterprise Value
      $10.61m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AARD Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AARD Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 04:02 PM

    Picture of Aardvark Therapeutics logoAardvark Therapeutics
    27/02/2026 21:02
    NASDAQ TRADE HALT  AARD.O  HALT NEWS PENDING AT 04:02 PM
    

    Recent news on Aardvark Therapeutics

    See all news
    • Brief: Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors

      08/10/2026 13:16
    • Aardvark Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary

      12/08/2026 15:41
    • Aardvark Therapeutics Q2 operating expenses fall on paused ARD-101 clinical trials and workforce reduction

      11/08/2026 22:04
    • Aardvark Therapeutics, Inc. expected to post a loss of 87 cents a share - Earnings Preview

      07/08/2026 14:55
    • U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark

      15/05/2026 18:46

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.